| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |